Abstract
The bile salt hydrolase (BSH) enzyme activities of human-derived lactic acid bacteria and bifidobacteria were evaluated. The highest enzyme activity was identified as 1.76 ± 0.23 U/mg protein for Bifidobacterium breve A26 and 1.42 ± 0.11 U/mg protein for Lactobacillus plantarum LA3. The bile salt deconjugation ability of the 6 isolates representing the highest BSH enzyme activity was calculated as the release of cholic acid and was between the range of 2.03 ± 0.22 and 1.05 ± 0.25 m<smlcap>M</smlcap>. The strains with high BSH enzyme activity also showed high deconjugation ability (p < 0.01). The effect of increasing bile concentrations on the growth of bacteria and their cholesterol removal abilities based on cholesterol precipitation were determined. Cholesterol removal in control medium was between 22.6 ± 0.4 and 26.5 ± 0.4%. The highest value was recorded at a 0.2% bile concentration. As the biliary concentration increased, a decrease in cholesterol removal and viability of the bacteria was noted in all strains. The percent of similarity of the bsh gene region between different genes was specified. The results may throw some light on proving the ability of these probiotics either as a novel alternative or as adjuvants to chemical drugs in treating hypercholesterolemia.
Journal Section:
Research Article
References
1.
Ahire JJ, Bhat AA, Thakare JM, Pawar PB, Zope DG, Jain RM, Chaudhari BL: Cholesterol assimilation and biotransformation by Lactobacillus helveticus. Biotechnol Lett 2012;34:103-107.
[PubMed]
2.
Ahrné S, Lönnermark E, Wold AE, Aberg N, Hesselmar B, Saalman R, Strannegard IL, Molin G, Adlerberth I: Lactobacilli in the intestinal microbiota of Swedish infants. Microbes Infect 2005;7:1256-1262.
[PubMed]
3.
Alp G, Aslim B: Relationship between the resistance to bile salts and low pH with exopolysaccharide (EPS) production of Bifidobacterium spp. isolated from infants feces and breast milk. Anaerobe 2010;16:101-105.
[PubMed]
4.
Begley M, Hill C, Gahan CGM: Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006;1729-1738.
[PubMed]
5.
Bradford MM: Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
[PubMed]
6.
Elkins CA, Moser SA, Savage DC: Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species. Microbiology 2001;147:3403-3412.
[PubMed]
7.
Gilliland SE, Nelson CR, Maxwell C: Assimilation of Cholesterol by Lacobacillus acidophilus. Appl Environ Microbiol 1985;49(2):377-381.
[PubMed]
8.
Homayouni A, Payahoo L, Azizi A: Effects of probiotics on lipid profile: a review. Am J Food Technol 2012;7:251-265.
9.
Jiang J, Hang X, Zhang M, Liu X, Li D, Yang H: Diversity of bile salt hydrolase activities in different lactobacilli toward human bile salts. Ann Microbiol 2010;60:81-88.
10.
Kaufmann P, Pfefferkorn A, Teuber M, Meile L: Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16s rRNA-targeted probes by colony hybridization and PCR. Appl Environ Microbiol 1997;63:1268-1273.
[PubMed]
11.
Kim GB, Yi SH, Lee BH: Purification and characterization of three different types of bile salt hydrolase from Bifidobacterium strains. J Dairy Sci 2004;87:258-266.
[PubMed]
12.
Kim G, Lee BH: Biochemical and molecular insights into bile salt hydrolase in the gastrointestinal microflora - a review. Asian Aust J Anim Sci 2005;18:1505-1512.
13.
Klaver FA, van der Meer R: The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 1993;59:1120-1124.
[PubMed]
14.
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, Yadav H: Cholesterol-lowering probiotics as potential biotherapeutics for metabolic disease. Exp Diabetes Res 2012;2012:1-14.
15.
Kültürsay N: Development of intestinal flora in infancy and its effects on immune system. J Pediatr Inf 2009;3:75-78.
16.
Lambert JM, Bongers RS, de Vos WM, Kleerebezem M: Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol 2008;74:4719-4726.
[PubMed]
17.
Lane DJ: 16S/23S rRNA sequencing; in Stackebrandt E, Goodfellow M (eds): Nucleic Acid Techniques in Bacterial Systematics. New York, John Wiley and Sons, 1991, pp 115-175.
18.
Lee J, Kim Y, Yun HS, Kim JG, Oh S, Kim SH: Genetic and proteomic analysis of factors affecting serum cholesterol reduction by Lactobacillus acidophilus A4. Appl Environ Microbiol 2010;76:4829-4835.
[PubMed]
19.
Li G: Intestinal probiotics: interactions with bile salts and reduction of cholesterol. Procedia Environ Sci 2012;12:1180-1186.
20.
Liong MT, Shah NP: Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci 2005;88:55-66.
[PubMed]
21.
Liong MT, Shah NP: Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J 2005;15:391-398.
22.
Lye HS, Rahmat-Ali GR, Liong MT: Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J 2010;20:169-175.
23.
Maria Isabel TD, Correira MD, Juliana C. Liboredo RD, Marcella LD, Consoli RD: The role of probiotics in gastrointestinal surgery. Nutrition 2012;28:230-234.
[PubMed]
24.
McAuliffe O, Cano RJ, Klaenhammer TR: Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2005;71:4925-4929.
[PubMed]
25.
Ooi LG, Liong MT: Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010;11:2499-2522.
[PubMed]
26.
Pärtty A, Kalliomäki M, Endo A, Salminen S, Isolauri E: Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS One 2012;7:e32495.
[PubMed]
27.
Patel AK, Singhania RR, Pandey A, Chincholkar SB: Probiotic bile salt hydrolase: current developments and perspectives. Appl Biochem Biotechnol 2010;162:166-180.
[PubMed]
28.
Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F: The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 2002;99:14422-144227.
[PubMed]
29.
Sirilun S, Chaiyasut C, Kantachote D, Luxananil P: Characterisation of non human origin probiotic Lactobacillus plantarum with cholesterol-lowering property. Afr J Microbiol Res 2010:4:994-1000.
30.
Sridevi N, Vishwe P, Prabhune A: Hypocholesteremic effect of bile salt hydrolase from Lactobacillus buchneri ATCC 4005. Food Res Int 2009;42:516-520.
31.
Tanaka H, Hashiba H, Kok J, Mierau I: Bile salt hydrolase of Bifidobacterium longum: biochemical and genetic characterization. Appl Environ Microbiol 2000;66:2502-2512.
[PubMed]
32.
Turner S, Pryer KM, Miao VP, Palmer JD: Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J Eukaryot Microbiol 1999;46:327-338.
[PubMed]
33.
Wasilewska E, Bielecka M: Isolation and identification of bifidobacteria from infant gut. Pol J Food Nutr Sci 2003;12:90-94.
34.
Walker DK, Gilliland SE: Relationship among bile tolerance, bile salt deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. J Dairy Sci 1993;76:956-961.
[PubMed]
35.
Yildiz GG, Öztürk M, Aslim B: Identification of Lactobacillus strains from breast-fed infant and investigation of their cholesterol-reducing effects. World J Microbiol Biotechnol 2011;27:2397-2406.
© 2013 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.
